Published in Proc Natl Acad Sci U S A on March 14, 2000
Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat Cell Biol (2010) 6.41
Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol (2002) 2.76
Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem (2010) 2.21
Amyotrophic lateral sclerosis: a proposed mechanism. Proc Natl Acad Sci U S A (2002) 1.86
Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. Am J Physiol Heart Circ Physiol (2006) 1.81
Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev (2008) 1.81
Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat Rev Drug Discov (2011) 1.71
Specificity in intracellular protein aggregation and inclusion body formation. Proc Natl Acad Sci U S A (2001) 1.62
Sequence composition of disordered regions fine-tunes protein half-life. Nat Struct Mol Biol (2015) 1.55
An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta -fibrils. Proc Natl Acad Sci U S A (2001) 1.38
Stress and prions: lessons from the yeast model. FEBS Lett (2007) 1.38
Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease. Proc Natl Acad Sci U S A (2000) 1.28
A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genet (2012) 1.20
Huntington's Disease. Cold Spring Harb Perspect Biol (2011) 1.11
Hsp40 chaperones promote degradation of the HERG potassium channel. J Biol Chem (2009) 1.09
The chaperone-like protein HYPK acts together with NatA in cotranslational N-terminal acetylation and prevention of Huntingtin aggregation. Mol Cell Biol (2010) 1.07
Chaperone effects on prion and nonprion aggregates. Prion (2007) 1.06
In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J Biol Chem (2011) 1.05
A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death. J Cell Biol (2004) 1.05
Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy. PLoS One (2010) 1.02
Amyloid in neurodegenerative diseases: friend or foe? Semin Cell Dev Biol (2011) 1.02
Hsp70 protein complexes as drug targets. Curr Pharm Des (2013) 1.00
Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1. J Cell Biol (2001) 1.00
Identification of the Drosophila ortholog of HSPB8: implication of HSPB8 loss of function in protein folding diseases. J Biol Chem (2010) 1.00
The ubiquitin-proteasome pathway in Huntington's disease. ScientificWorldJournal (2008) 0.99
Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex. Nat Commun (2013) 0.99
Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways. Prion (2009) 0.97
The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides. J Biol Chem (2013) 0.95
The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias. BMC Biochem (2007) 0.93
Misfolding of proteins with a polyglutamine expansion is facilitated by proteasomal chaperones. J Biol Chem (2008) 0.91
Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis. J Exp Med (2003) 0.91
Molecular chaperones and neuronal proteostasis. Semin Cell Dev Biol (2015) 0.91
NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. PLoS Biol (2016) 0.90
Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes. J Biol Chem (2013) 0.89
Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation. J Biol Chem (2011) 0.89
Prion propagation by Hsp40 molecular chaperones. Prion (2009) 0.87
Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregates. J Cell Biol (2001) 0.87
Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin. Biomed Res Int (2014) 0.87
Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition. PLoS One (2010) 0.85
Loss of a 20S proteasome activator in Saccharomyces cerevisiae downregulates genes important for genomic integrity, increases DNA damage, and selectively sensitizes cells to agents with diverse mechanisms of action. G3 (Bethesda) (2012) 0.84
The mechanism whereby heat shock induces apoptosis depends on the innate sensitivity of cells to stress. Cell Stress Chaperones (2009) 0.84
Co-chaperone HSJ1a dually regulates the proteasomal degradation of ataxin-3. PLoS One (2011) 0.84
Protein aggregates and dementia: is there a common toxicity? J Neurol Neurosurg Psychiatry (2002) 0.84
Pathology and function of nuclear amyloid. Protein homeostasis matters. Nucleus (2014) 0.83
Interplay between protein homeostasis networks in protein aggregation and proteotoxicity. Biopolymers (2010) 0.83
Detection of ubiquitinated huntingtin species in intracellular aggregates. Front Mol Neurosci (2015) 0.83
αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease. Hum Mol Genet (2016) 0.82
From pathways to targets: understanding the mechanisms behind polyglutamine disease. Biomed Res Int (2014) 0.81
The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease. J Neurol (2013) 0.81
Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation. PLoS Curr (2011) 0.81
Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease. Histochem Cell Biol (2007) 0.81
siRNA screen identifies QPCT as a druggable target for Huntington's disease. Nat Chem Biol (2015) 0.81
DnaJ homolog Hdj2 facilitates Japanese encephalitis virus replication. Virol J (2011) 0.79
Reductions of the components of the calreticulin/calnexin quality-control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease. J Neurosci Res (2014) 0.79
Modeling Huntington disease in Drosophila: Insights into axonal transport defects and modifiers of toxicity. Fly (Austin) (2013) 0.78
The Copper Metabolism MURR1 domain protein 1 (COMMD1) modulates the aggregation of misfolded protein species in a client-specific manner. PLoS One (2014) 0.78
Graded Proteasome Dysfunction in Caenorhabditis elegans Activates an Adaptive Response Involving the Conserved SKN-1 and ELT-2 Transcription Factors and the Autophagy-Lysosome Pathway. PLoS Genet (2016) 0.78
Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease. Front Cell Neurosci (2014) 0.78
Hydrodynamic size-based separation and characterization of protein aggregates from total cell lysates. Nat Protoc (2014) 0.78
Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease. Nat Commun (2017) 0.78
Dose-dependent neuroprotection of VEGF₁₆₅ in Huntington's disease striatum. Mol Ther (2013) 0.77
Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation. Sci Rep (2015) 0.77
DNAJ Proteins in neurodegeneration: essential and protective factors. Philos Trans R Soc Lond B Biol Sci (2018) 0.76
Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival. Prog Retin Eye Res (2016) 0.76
Role of Carbonyl Modifications on Aging-Associated Protein Aggregation. Sci Rep (2016) 0.76
The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations. J Neural Transm (Vienna) (2014) 0.76
Establishment of a suite of assays that support the discovery of proteasome stimulators. Biochim Biophys Acta (2017) 0.75
Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders. Mol Neurobiol (2016) 0.75
Proteostasis of Huntingtin in Health and Disease. Int J Mol Sci (2017) 0.75
Molecular chaperones in cellular protein folding. Nature (1996) 14.00
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science (1997) 11.53
Ubiquitin-dependent protein degradation. Annu Rev Genet (1996) 10.97
Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem (1996) 10.70
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57
Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell (1998) 7.69
Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem (1993) 7.53
Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell (1998) 7.13
Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell (1998) 6.24
Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet (1998) 4.27
Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet (1999) 4.06
Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron (1997) 3.73
DnaJ-like proteins: molecular chaperones and specific regulators of Hsp70. Trends Biochem Sci (1994) 3.65
Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem Sci (1999) 3.48
Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature (1997) 3.16
Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem (1997) 2.80
Antagonistic interactions between yeast chaperones Hsp104 and Hsp70 in prion curing. Mol Cell Biol (1999) 2.69
Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet (1998) 2.42
Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet (1998) 2.39
The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem (1997) 2.24
The conserved carboxyl terminus and zinc finger-like domain of the co-chaperone Ydj1 assist Hsp70 in protein folding. J Biol Chem (1998) 2.13
Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet (1999) 1.98
Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis (1998) 1.96
Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet (1999) 1.95
Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol (1998) 1.93
Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet (1998) 1.91
The influence of huntingtin protein size on nuclear localization and cellular toxicity. J Cell Biol (1998) 1.87
A cellular model that recapitulates major pathogenic steps of Huntington's disease. Hum Mol Genet (1998) 1.87
Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J Neurochem (1999) 1.66
Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet (1998) 1.64
Proteasome inhibition leads to the activation of all members of the heat-shock-factor family. Eur J Biochem (1998) 1.41
Proteasome inhibitors MG132 and lactacystin hyperphosphorylate HSF1 and induce hsp70 and hsp27 expression. Biochem Biophys Res Commun (1999) 1.31
Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts? J Med Genet (1999) 1.03
Adenovirus-mediated expression of mutant DRPLA proteins with expanded polyglutamine stretches in neuronally differentiated PC12 cells. Preferential intranuclear aggregate formation and apoptosis. Hum Mol Genet (1999) 0.98
Depressed expression of the inducible form of HSP 70 (HSP 72) in brain and heart after in vivo heat shock. Am J Physiol (1995) 0.85
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet (2000) 12.56
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res (1987) 10.80
The vexed question of authorship: views of researchers in a British medical faculty. BMJ (1997) 10.22
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language. Am J Hum Genet (2000) 4.72
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J Clin Oncol (1997) 3.61
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol (1999) 3.48
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Atopy in children of families with an anthroposophic lifestyle. Lancet (1999) 3.41
Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med (1997) 3.33
Public Health Outreach Forum: lessons learned. Bull Med Libr Assoc (2001) 3.00
Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL. Cell Death Differ (2009) 2.85
Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ (2008) 2.65
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res (1987) 2.56
The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev (2008) 2.39
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol (1997) 2.39
A nationally representative study of maternal obesity in England, UK: trends in incidence and demographic inequalities in 619 323 births, 1989-2007. Int J Obes (Lond) (2009) 2.38
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer. Br J Cancer (2000) 2.30
Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer. Lancet (1990) 2.25
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee. J Natl Cancer Inst (1993) 2.22
Microsatellites show mutational bias and heterozygote instability. Nat Genet (1996) 2.18
Congenital anomaly surveillance in England--ascertainment deficiencies in the national system. BMJ (2004) 2.06
Register based study of bladder exstrophy-epispadias complex: prevalence, associated anomalies, prenatal diagnosis and survival. J Urol (2011) 2.03
Cancer in minority ethnic populations: priorities from epidemiological data. Br J Cancer Suppl (1996) 1.99
A molecular investigation of true dominance in Huntington's disease. J Med Genet (1999) 1.92
Cancer-related fatigue: A critical appraisal. Eur J Cancer (2006) 1.90
Network analysis of human Y microsatellite haplotypes. Hum Mol Genet (1996) 1.89
Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain (1998) 1.84
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum Mol Genet (2001) 1.81
Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet (1999) 1.79
Corticosteroid resistance in chronic asthma. Br Med J (Clin Res Ed) (1981) 1.75
An empirical exploration of the (delta mu)2 genetic distance for 213 human microsatellite markers. Am J Hum Genet (1999) 1.66
Moderate drinking and health: report of an international symposium. CMAJ (1994) 1.65
Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Intern Med J (2007) 1.63
A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer. Eur J Cancer (2002) 1.62
Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Med Care (2001) 1.61
Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab (1970) 1.57
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer. Br J Cancer (2001) 1.56
Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma. Br J Dis Chest (1982) 1.55
The benefits of HIV antibody testing of saliva in field research. Can J Public Health (1992) 1.54
Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect Immun (1994) 1.51
Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis. J Med Genet (2000) 1.50
Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Mov Disord (1997) 1.49
Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst (1993) 1.49
Respiratory abnormalities among grain handlers: a clinical, physiologic, and immunologic study. Am Rev Respir Dis (1977) 1.48
Is it possible to catch leukaemia from a cat? Lancet (1994) 1.47
Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl) (2005) 1.43
Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma. Br Med J (1979) 1.41
Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ (2007) 1.41
Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med (1985) 1.39
The long-term prognosis in farmer's lung. Am Rev Respir Dis (1968) 1.36
Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res (1987) 1.34
Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer. J Natl Cancer Inst (2000) 1.33
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. Br J Cancer (2011) 1.31
Congenital anterior abdominal wall defects. Authors' figures for Northern region are underestimates. BMJ (1997) 1.30
Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity. Oncogene (1993) 1.30
Characterisation of the coding sequence and fine mapping of the human DFFRY gene and comparative expression analysis and mapping to the Sxrb interval of the mouse Y chromosome of the Dffry gene. Hum Mol Genet (1998) 1.30
A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene (1997) 1.29
Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease. Proc Natl Acad Sci U S A (2000) 1.28
Epidemiologic study of clinical and physiologic parameters in grain handlers of northern United States. Am Rev Respir Dis (1984) 1.24
Formaldehyde vapor in mobile homes: a cross sectional survey of concentrations and irritant effects. Am J Public Health (1984) 1.22
Obesity in pregnancy: a study of the impact of maternal obesity on NHS maternity services. BJOG (2007) 1.22
Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest (1997) 1.22
Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy (2000) 1.22
The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology (1990) 1.21
Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet (1998) 1.20
Chemotherapy for ovarian cancer--a consensus statement on standard practice. Br J Cancer (1998) 1.19
Ambient air pollution and risk of congenital anomalies in England, 1991-1999. Occup Environ Med (2009) 1.19
Action spectra of lupus erythematosus and experimental immunofluorescence. Arch Dermatol (1973) 1.18
The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2. Hum Mol Genet (1996) 1.18
Farmer's lung disease: long-term clinical and physiologic outcome. Am Rev Respir Dis (1979) 1.17
Public Health Outreach Forum: report. Bull Med Libr Assoc (2001) 1.17
Pulmonary granulomatoses due to inhaled organic antigens. Med Clin North Am (1967) 1.16
Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis (1995) 1.16
Ascertainment bias cannot entirely account for human microsatellites being longer than their chimpanzee homologues. Hum Mol Genet (1998) 1.16
Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1992) 1.15
Markov chain Monte Carlo analysis of human Y-chromosome microsatellites provides evidence of biased mutation. Proc Natl Acad Sci U S A (1999) 1.15
Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia (2012) 1.14
Metabolic oscillations in an E. coli fermentation. Biotechnol Bioeng (2001) 1.13
Production of scatter factor by ndk, a strain of epithelial cells, and inhibition of scatter factor activity by suramin. J Cell Sci (1991) 1.12
Comparative nuclear and mitochondrial genome diversity in humans and chimpanzees. Mol Biol Evol (1997) 1.11
Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours. Br J Cancer (2012) 1.11
The ACE gene and Alzheimer's disease susceptibility. J Med Genet (2000) 1.11
Multiple self-healing squamous epitheliomata (ESS1) mapped to chromosome 9q22-q31 in families with common ancestry. Nat Genet (1993) 1.10
The sensitivity of human tumour cells to quinone bioreductive drugs: what role for DT-diaphorase? Biochem Pharmacol (1992) 1.10
Maternal body mass index and the risk of fetal and infant death: a cohort study from the North of England. Hum Reprod (2011) 1.08
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma. Eur J Cancer (2004) 1.08
Changing patterns of perinatal death, 1982-2000: a retrospective cohort study. Arch Dis Child Fetal Neonatal Ed (2004) 1.08
A phase II trial of marimastat in advanced pancreatic cancer. Br J Cancer (2001) 1.08
Loss of CD59 expression in breast tumours correlates with poor survival. J Pathol (2003) 1.07
Implementation of pregnancy weight management and obesity guidelines: a meta-synthesis of healthcare professionals' barriers and facilitators using the Theoretical Domains Framework. Obes Rev (2014) 1.07
Polyalanine and polyserine frameshift products in Huntington's disease. J Med Genet (2006) 1.06
A dinucleotide repeat polymorphism at the D9S127 locus. Nucleic Acids Res (1992) 1.06